TVRD
Tvardi Therapeutics
TVRD
TVRD
130 hedge funds and large institutions have $360M invested in Tvardi Therapeutics in 2018 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 37 increasing their positions, 32 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
11% more call options, than puts
Call options by funds: $21.7M | Put options by funds: $19.5M
7% more funds holding
Funds holding: 121 → 130 (+9)
0.1% more ownership
Funds ownership: 1.52% → 1.63% (+0.1%)
Holders
130
Holding in Top 10
2
Calls
$21.7M
Puts
$19.5M
Top Buyers
| 1 | +$11.6M | |
| 2 | +$7.18M | |
| 3 | +$6.68M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$4.75M |
| 5 |
Goldman Sachs
New York
|
+$3.48M |
Top Sellers
| 1 | -$17.3M | |
| 2 | -$3.09M | |
| 3 | -$2.17M | |
| 4 |
DZ Bank
Frankfurt Am Main,
Germany
|
-$990K |
| 5 |
California Public Employees Retirement System
Sacramento,
California
|
-$944K |